1-3 of 3
Atlantis Dawn Russ, MD PhD
Close
Sort by
Journal Articles

A Decade of Drug Development through Phase-1 Trials; Systematic Review of Literature for Novel Drugs and Targets in Multiple Myeloma

Imad Ud Deen, MBBS, Muhammad Umar Khalid, MD, Atlantis Dawn Russ, MD PhD, Anh Hua, BS, Ahmad Iftikhar, MD, Adeela Mushtaq, MD, Ahmad Safdar, BS, Ali McBride, PharmD,MS, Faiz Anwer, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5399.
https://doi.org/10.1182/blood.V130.Suppl_1.5399.5399
Published: 2017
Journal Articles

Precision Therapy Targeting Signal Transduction Aberrant Pathways in Multiple Myeloma

Raahem Nayab Zafar, BS, Atlantis Dawn Russ, MD PhD, Ahmad Iftikhar, MD, Azka Latif, MD, Vikas Kapoor, MD, Faiza Hassan Warraich, MD, Sami Ullah Warraich, MBBS, Pavan Tenneti, MD, Mirza Zeeshan Baig, MD, Ali McBride, PharmD,MS, Faiz Anwer, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5403.
https://doi.org/10.1182/blood.V130.Suppl_1.5403.5403
Published: 2017
Journal Articles

Efficacy and Toxicity Profile of Carfilzomib Based Regimens for Treatment of Multiple Myeloma, a Systematic Review

Adeela Mushtaq, MD, Azka Latif, MD, Vikas Kapoor, MD, Faiza Hassan Warraich, MD, Sami Ullah Warraich, MBBS, Ahmad Iftikhar, MD, Pavan Tenneti, MD, Raahem Nayab Zafar, BS, Atlantis Dawn Russ, MD PhD, Ivo Abraham, PhD RN, Ali McBride, PharmD,MS, Faiz Anwer, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5413.
https://doi.org/10.1182/blood.V130.Suppl_1.5413.5413
Published: 2017